,i #aafth ,,congress #ast ,session ,h4 ,r4 #dfcc ,,in ,,the ,,house ,,of ,,representatives ,october #aa1 #bjai,ms4 ,eshoo 7for herself and ,mr4 ,peters7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the #bast ,century ,cures ,act to reauthorize funding for ,,fda innovation projects1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,investing in ,safety and ,innovation ,act of #bjai4 #b4 ,reauthorization of ,,fda ,innovation ,projects 7a7 ,transfer of direct spending savings ,section #ajjb7;b77#b77;,a7 of the #bast ,century ,cures ,act 7,public ,law #aad-bee7 is amended-- 7#a7 in the matter preceding clause 7i71 by striking #bjbe and inserting #bjbi2 and 7#b7 by striking clauses 7iv7 through 7ix7 and inserting the following3 7iv7 ,for fiscal year #bjbj1 #gdf1jjj1jjj4 7v7 ,for fiscal year #bjba1 #eea1jjj1jjj4 7vi7 ,for each of fiscal years #bjbb through #bjbd1 #eca1jjj1jjj4 7vii7 ,for fiscal year #bjbe1 #ecf1jjj1jjj4 7viii7 ,for each of fiscal years #bjbf through #bjbi1 #eca1jjj1jjj4 4 7b7 ,,fda ,activities ,paragraph 7#d7 of section #ajjb7;b7 of the #bast ,century ,cures ,act 7,public ,law #aad-bee7 is amended to read as follows3 7#d7 ,,fda activities ,the activities authorized to be funded under this section shall consist of the following1 and of the total amounts authorized to be appropriated under paragraph 7#c7 there are authorized to be appropriated to each category of activities a total amount not to exceed the following3 7,a7 ,in addition to the allocations specified in subparagraphs 7,b7 through 7,k71 for the activities under subtitles ,a through ,f 7including the amendments made by such subtitles7 of title ,,iii of this ,act and section #ajad of the ,federal ,food1 ,drug1 and ,cosmetic ,act1 as added by section #cjgc of this ,act3 7i7 ,for fiscal year #bjbj1 #ge1jjj1jjj4 7ii7 ,for fiscal year #bjba1 #gj1jjj1jjj4 7iii7 ,for each of fiscal years #bjbb through #bjbd1 #ej1jjj1jjj4 7iv7 ,for fiscal year #bjbe1 #ee1jjj1jjj4 7v7 ,for each of fiscal years #bjbf through #bjbi1 #ej1jjj1jjj4 7,b7 ,for modernization of the technical infrastructure of the ,food and ,drug ,administration1 including enhancements such as interoperability across the agency1 and additional capabilities to develop an advanced information technology infrastructure to support the agency's regulatory mission3 7i7 ,for fiscal year #bjbj1 #cjj1jjj1jjj4 7ii7 ,for each of fiscal years #bjba through #bjbi1 #bjj1jjj1jjj4 7,c7 ,for support for continuous manufacturing of drugs and biological products1 including complex biological products such as regenerative medicine therapies1 through grants to institutions of higher education and nonprofit organizations and other appropriate mechanisms1 for each of fiscal years #bjbj through #bjbi1 #ej1jjj1jjj4 7,d7 ,for support for the ,commissioner of ,food and ,drugs to engage experts1 such as through the formation and operation of public-private partnerships or other appropriate collaborative efforts1 to advance the development and delivery of individualized human gene therapy products3 7i7 ,for fiscal year #bjbj1 #ej1jjj1jjj4 7ii7 ,for each of fiscal years #bjba through #bjbi1 #aj1jjj1jjj4 7,e7 ,for support for inspections and enforcement activities across the ,food and ,drug ,administration1 including foreign and domestic facility inspections across products1 for each of fiscal years #bjbj through #bjbi1 #hb1ejj1jjj4 7,f7 ,for support for activities of the ,food and ,drug ,administration related to customs and border protection to provide improvements to technologies1 inspection capacity1 and international mail facilities in which the ,food and ,drug ,administration operates1 for each of fiscal years #bjbj through #bjbi1 #be1jjj1jjj4 7,g7 ,to further advance the development of a coordinated postmarket surveillance system for all medical products1 including drugs1 biological products1 and devices1 linked to electronic health records in furtherance of the ,food and ,drug ,administration's postmarket surveillance capabilities3 7i7 ,for fiscal year #bjbj1 #ajj1jjj1jjj4 7ii7 ,for each of fiscal years #bjba through #bjbi1 #ej1jjj1jjj4 7,h7 ,for support for ,food and ,drug ,administration activities to keep pace with the projected product development of regenerative therapies1 including human somatic cellular and gene therapies1 for each of fiscal years #bjbj through #bjbi1 #be1jjj1jjj4 7,i7 ,for support for the development of non-opioid pharmacological therapies as alternatives for opioids1 for each of fiscal years #bjbj through #bjbi1 #c1ejj1jjj4 7,j7 ,for carrying out section #gad;,a of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;d-#c;a2 relating to hiring authority for scientific1 technical1 and professional personnel71 for each of fiscal years #bjbj through #bjbi1 #bj1jjj1jjj4 7,k7 ,for the ,food and ,drug ,administration to support improvements to the technological infrastructure for reporting and analysis of adverse events associated with the use of drugs and biological products1 for each of fiscal years #bjbj through #bjbi1 #ae1jjj1jjj4 4 7c7 ,annual reports ,section #ajjb7;c77#b77;,a7 of the #bast ,century ,cures ,act 7,public ,law #aad-bee7 is amended by striking #bjbf and inserting #bjbi4 7d7 ,sunset ,section #ajjb7;e7 of the #bast ,century ,cures ,act 7,public ,law #aad-bee7 is amended by striking ,september #cj1 #bjbf and inserting ,september #cj1 #bjbi4